Skip to main content
Lunit Inc. logo

Lunit Inc. — Investor Relations & Filings

Ticker · 328130 ISIN · KR7328130000 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 307 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country KR South Korea
Listing KO 328130

About Lunit Inc.

https://www.lunit.io/

Lunit Inc. develops and provides advanced medical artificial intelligence (AI) software focused on cancer diagnostics and therapeutics. The company's core offering is a platform-based AI ecosystem designed to analyze and interpret medical data, including radiological images and pathology slides. Its solutions, such as the Lunit INSIGHT suite for mammography and chest X-ray analysis, assist healthcare professionals in the early detection of cancer, enhancing diagnostic accuracy and workflow efficiency. In precision oncology, Lunit's AI technology supports biomarker discovery and treatment response prediction by analyzing tissue pathology. The company also collaborates with biopharmaceutical partners to accelerate oncology drug development and create AI-powered companion diagnostics. Lunit's platform integrates multimodal data to provide actionable insights across the cancer care continuum, from screening to treatment.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Regulatory Filings
2026-04-30 Korean
증권발행실적보고서
Regulatory Filings
2026-04-30 Korean
유상증자또는주식관련사채등의청약결과(자율공시)
Share Issue/Capital Change Classification · 1% confidence The document is a voluntary disclosure detailing the results of a rights offering (paid‐in capital increase) including subscription quantities, allocation ratios, and key dates. This is an announcement related to a new share issuance / capital change. Therefore, it fits the Share Issue/Capital Change category.
2026-04-24 Korean
[기재정정]주요사항보고서(유무상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a Korean "주요사항보고서(유무상증자결정) 정정신고"—a correction to a previously filed major event report regarding both paid-in capital increase (유상증자) and bonus share issuance (무상증자). It details the number of new shares, pricing, allocation method, and timing of the stock issuance. This is clearly an announcement of a share issue/capital change. Under the provided taxonomy, it falls squarely into the Share Issue/Capital Change category (SHA).
2026-04-20 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 1% confidence The document is titled “증권신고서(지분증권)” and details a paid-in capital increase via a rights offering and general public subscription of 7,906,816 new common shares, including amendments (“정정”) to the originally filed securities registration statement. It is not an earnings release, management change, or simple announcement of publication; rather, it is the actual regulatory filing for a share issuance (capital increase) under Korean capital markets law. Therefore, it best fits the Share Issue/Capital Change category (Code: SHA).
2026-04-20 Korean
[기재정정]투자설명서
Share Issue/Capital Change Classification · 1% confidence The document is a corrected “투자설명서” (investment prospectus/securities registration statement) for a new share issuance by the company (rights offering and public offering of unsubscribed shares). It is not a short notice or mere announcement of a report but the full, amended prospectus detailing the issuance terms, pricing, use of proceeds, subscription procedures, etc. This clearly falls under the “Share Issue/Capital Change” category.
2026-04-20 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.